Skip to content

ESPB vs TPVB for Postoperative Analgesia After the Nuss Procedure

Comparison of Erector Spinae Plane and Paravertebral Nerve Blocks for Postoperative Analgesia in Children After the Nuss Procedure

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05034601
Enrollment
68
Registered
2021-09-05
Start date
2021-09-25
Completion date
2023-03-23
Last updated
2023-11-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Analgesia, Nerve Block, Pectus Excavatum

Brief summary

This is a prospective randomized double-blind non-inferiority trial designed to test the hypothesis that erector spinae plane block (ESPB) is non-inferior to thoracic paravertebral block (TPVB) in postoperative pain control after pectus excavatum repair.

Interventions

PROCEDUREESPB group

A 21-gauge 100-mm needle will be inserted into the fascial layer beneath the iliocostalis, longissimus, and spinalis muscles. A bolus of 0.25% ropivacaine 0.5 ml/kg will be injected into the fascial layer. Contralateral ESPB will be performed similarly.

PROCEDURETPVB group

A 21-gauge 100-mm insulated needle will be inserted into the paravertebral space via an in-plane parasagittal approach. After perforating the costotransverse ligament, 0.25% ropivacaine 0.5 ml/kg will be injected. Anterior movement of the pleura indicated the appropriate spread of the local anesthetics in the paravertebral space. The process will be repeated on the contralateral side.

Sponsors

West China Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
TRIPLE (Subject, Caregiver, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
4 Years to 18 Years
Healthy volunteers
No

Inclusion criteria

* Age between 4 to 18 years Scheduled for elective Nuss surgery Written informed consent is obtained from parents of each patient.

Exclusion criteria

* Coagulation dysfunction. American Society of Anesthesiologists Physical Status 4 or 5. Allergy to study medication. Local infection at the site of injection or systemic infection. Inability to understand Chinese.

Design outcomes

Primary

MeasureTime frameDescription
Pain scores at rest at 24 hours postoperatively24 hours postoperativelyPain scores will be recorded using the Numeric Rating Scale (NRS) scores (0-10).

Secondary

MeasureTime frameDescription
total rescue morphine-equivalent consumption per weightat 24 and 48 hours after surgerytotal rescue morphine-equivalent consumption per weight at predetermined time intervals (24 and 48 hours) after surgery
Emergence agitation at 5, 15, 30 min after extubationat 5, 15, 30 min after extubationEmergence agitation will be registered using pediatric anesthesia emergence delirium (PAED) at 5, 15, 30 min after extubation
Total dosage of intraoperative sufentanil and remifentanilduring surgeryTotal dosage of intraoperative sufentanil and remifentanil per weight
The pain degree at rest and after movement or coughing(dynamic)at 3, 6, 12, 24, and 48 hours after surgeryThe pain degree at rest and after movement or coughing at 3, 6, 12, 24, and 48 hours after surgery respectively.
The time to first mobilizationwithin the 3 days after surgeryTime from operation to ambulation
Side effectswithin the 5 days after surgerySide effects such as pneumothorax, local anesthetic toxicity, postoperative nausea and vomiting
The time to first analgesia requestwithin the 3 days after surgeryTime from operation to first rescue analgesia request

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 19, 2026